Riskpilot← Back to searchSign inGet full accessRehab-Partner ApS
APSActiveCVR 31052726Jordkærvej 29Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20072 employeeswww.rehab-partner.dk
Revenue 2025
DKK 2,4M
-28% vs 2024
EBITDA margin
52.3%
-43% vs 2024
Equity ratio
38.0%
Financial strength
Net profit 2025
DKK 542K
-60% vs 2024
| Revenue | DKK 2,4M | -28% |
| EBITDA | DKK 1,3M | -43% |
| Net profit | DKK 542K | -60% |
| Total assets | DKK 10,4M | -14% |
| Equity | DKK 3,9M | -27% |
| Employees | 2 | — |
Legal name
Rehab-Partner ApS
CVR number
31052726
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. november 2007
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen i fællesskab.
Company purpose
Selskabets formål er import og salg af plejeudstyr til sundhedssektoren og dermed beslægtet virksomhed.
Address
Jordkærvej 29
Phone
+4586801807
Email
info@rehab-partner.dk
Website
www.rehab-partner.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.361 | 1.478 | 1.650 | 1.559 | 2.409 | 1.579 | 3.073 | 2.319 | 2.693 | 3.025 | 1.518 | 2.608 | 3.394 | 2.427 |
| Staff expenses | -282 | -675 | -848 | -778 | -1.056 | -1.044 | -1.622 | -1.513 | -1.767 | -1.631 | -794 | -1.180 | -1.180 | -1.157 |
| EBITDA | 1.079 | 803 | 802 | 781 | 1.353 | 535 | 1.451 | 806 | 926 | 1.394 | 724 | 1.428 | 2.214 | 1.270 |
| Depreciation & amort. | -69 | -30 | -36 | -86 | -60 | -75 | -195 | -370 | -370 | -313 | -163 | -312 | -148 | -85 |
| EBIT | 1.010 | 773 | 766 | 695 | 1.293 | 460 | 1.257 | 436 | 556 | 1.081 | 561 | 1.116 | 2.066 | 1.185 |
| Net financials | -264 | -212 | -222 | -188 | -160 | -77 | -166 | -130 | -177 | -159 | -68 | -179 | -281 | -466 |
| Profit before tax | 746 | 561 | 544 | 507 | 1.133 | 383 | 1.091 | 305 | 379 | 922 | 493 | 936 | 1.785 | 719 |
| Tax | 201 | 155 | 137 | 135 | 278 | 95 | 251 | 87 | 91 | 211 | 103 | 220 | 416 | 176 |
| Net profit | 545 | 406 | 406 | 371 | 855 | 288 | 840 | 218 | 288 | 711 | 390 | 717 | 1.369 | 542 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.978 | 3.401 | 4.927 | 4.366 | 5.947 | 6.486 | 9.816 | 12.517 | 7.946 | 11.688 | 10.283 | 9.464 | 12.101 | 10.375 |
| Equity | -142 | 264 | 671 | 1.042 | 1.898 | 2.185 | 3.025 | 3.244 | 2.754 | 3.226 | 3.356 | 4.073 | 5.442 | 3.947 |
| Long-term debt | 612 | 569 | 484 | 359 | 251 | 190 | 354 | 293 | 201 | 97 | 170 | 222 | 2.046 | 1.448 |
| Short-term debt | 3.508 | 2.567 | 3.773 | 2.966 | 3.799 | 4.111 | 6.436 | 8.979 | 4.991 | 8.364 | 6.757 | 5.170 | 4.613 | 4.980 |
| Total debt | 4.120 | 3.137 | 4.257 | 3.324 | 4.050 | 4.301 | 6.790 | 9.273 | 5.192 | 8.461 | 6.927 | 5.391 | 6.659 | 6.428 |
EBITDA margin
52.3%
This company
15.8%
Market median
+231% vs market
20122025
Equity ratio
38.0%
This company
38.2%
Market median
+1% vs market
20122025
Return on equity
13.7%
This company
18.4%
Market median
+26% vs market
20122025
Net profit margin
22.3%
This company
8.1%
Market median
+175% vs market
20122025
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20122025
Debt / equity
1.63×
This company
0.62×
Market median
-163% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HG Management | Management | 2007 | — | — |
SV Management | Management | 2021 | — | — |
MS Management | Management | 2009 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SAMI ApS | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SAMI ApS
Rehab-Partner ApS Board members of Rehab-Partner ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Guldager Dalgaard Knudsen | Management | 0 companies |
| Sanja Valbjørn Skivesen | Management | 0 companies |
| Michael Skivesen | Management | 0 companies |